Jefferies Maintains Sarepta Therapeutics(SRPT.US) With Buy Rating, Maintains Target Price $165

Futu NewsJan 2 23:31 · Ratings

Analysts Offer Insights on Healthcare Companies: Eli Lilly & Co (LLY), Kymera Therapeutics (KYMR) and Sarepta Therapeutics (SRPT)

TipRanksJan 2 23:20 · Ratings

Sarepta Therapeutics: Buy Rating Backed by Elevidys Growth and Diversified Pipeline

TipRanksJan 2 21:15 · Ratings

Sarepta Therapeutics Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

BusinesswireJan 1 05:10

Express News | Sarepta Therapeutics Announces Inducement Grants Under Nasdaq Listing Rule 5635(C)(4)

BreakingsJan 1 05:10

Sarepta Therapeutics, Inc. (SRPT): Is This Gene Therapy Stock a Good Buy Right Now?

Yahoo FinanceDec 29, 2024 19:45